For decades, progress in medicine has followed a predictable pattern: technology advances, outcomes improve, and human labor evolves. Today, however, that trajectoryFor decades, progress in medicine has followed a predictable pattern: technology advances, outcomes improve, and human labor evolves. Today, however, that trajectory

Scalpel vs. Silicon: Why Surgery Will Never Be Fully Automated

For decades, progress in medicine has followed a predictable pattern: technology advances, outcomes improve, and human labor evolves. Today, however, that trajectory is being questioned more radically than ever.

In a series of public statements, Elon Musk has suggested that artificial intelligence and robotics may soon outperform human surgeons altogether. His logic is straightforward—machines do not fatigue, algorithms learn faster than people, and automation scales with precision. If surgery is simply a matter of accuracy and repeatability, the argument goes, then human doctors may eventually become unnecessary.

But inside operating rooms across the world, a quieter, more grounded reality tells a different story.

Dr Bülent Cihantimur—internationally known and founder of Estetik International —has

 spent decades performing complex aesthetic and reconstructive procedures. His response to the idea of fully automated surgery is neither defensive nor nostalgic. It is clinical.

According to Dr Cihantimur, the core limitation of automation in surgery is not technological. It is biological.

No two patients are the same.

Even when procedures are identical on paper, outcomes are not. Tissue elasticity varies. Vascular structures differ. Healing capacity changes from person to person. Pain tolerance, immune response, and post-operative recovery are deeply individual processes that cannot be fully standardised.

More importantly, surgery is not performed on bodies alone—it is performed on people.

Artificial intelligence excels at recognizing patterns across massive datasets. It can assist in diagnostics, planning, and even robotic precision. These tools already enhance modern surgical practice, and Dr. Cihantimur actively supports their integration when used responsibly.

What machines cannot do, however, is interpret context in real time.

A surgeon makes hundreds of micro-decisions during a single procedure—adjustments based on tactile feedback, visual nuance, and unexpected anatomical variations. These decisions are shaped by experience, accountability, and judgment developed over years of hands-on practice.

A machine may calculate where to cut.
Only a human understands when not to.

This distinction becomes even more critical when complications arise. Technology does not carry moral responsibility. It does not speak with patients when outcomes differ from expectations. It does not absorb accountability when irreversible decisions must be explained.

At institutions like Estetik International, technology functions as an extension of human expertise—not a substitute for it. Advanced imaging, data-driven planning, and precision tools support the surgeon’s hand, but they do not replace the surgeon’s role as decision-maker.

The future of surgery will undoubtedly be more technological than its past. But automation alone cannot replace the human capacity for judgment under uncertainty.

Precision can be automated.

Responsibility cannot.

As long as medicine involves human beings—each biologically unique and personally invested—the scalpel will remain guided by human hands.

Comments
Market Opportunity
Dogelon Mars Logo
Dogelon Mars Price(ELON)
$0.000000044
$0.000000044$0.000000044
-0.04%
USD
Dogelon Mars (ELON) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Top 4 Tokens Turning IP Rights Into Investable Assets

Top 4 Tokens Turning IP Rights Into Investable Assets

IP tokenization opens royalties to investors as BeatSwap, Audius, Story Protocol, and Opulous turn music and media rights into on-chain, income-backed assets.
Share
Blockchainreporter2026/01/21 17:45
‘Anti-Innovation’: Experts Slam Nigeria’s ‘Disproportionate’ Capital Requirements for Crypto Firms

‘Anti-Innovation’: Experts Slam Nigeria’s ‘Disproportionate’ Capital Requirements for Crypto Firms

The post ‘Anti-Innovation’: Experts Slam Nigeria’s ‘Disproportionate’ Capital Requirements for Crypto Firms appeared on BitcoinEthereumNews.com. The Nigerian SEC
Share
BitcoinEthereumNews2026/01/21 17:34
Why This New Trending Meme Coin Is Being Dubbed The New PEPE After Record Presale

Why This New Trending Meme Coin Is Being Dubbed The New PEPE After Record Presale

The post Why This New Trending Meme Coin Is Being Dubbed The New PEPE After Record Presale appeared on BitcoinEthereumNews.com. Crypto News 17 September 2025 | 20:13 The meme coin market is heating up once again as traders look for the next breakout token. While Shiba Inu (SHIB) continues to build its ecosystem and PEPE holds onto its viral roots, a new contender, Layer Brett (LBRETT), is gaining attention after raising more than $3.7 million in its presale. With a live staking system, fast-growing community, and real tech backing, some analysts are already calling it “the next PEPE.” Here’s the latest on the Shiba Inu price forecast, what’s going on with PEPE, and why Layer Brett is drawing in new investors fast. Shiba Inu price forecast: Ecosystem builds, but retail looks elsewhere Shiba Inu (SHIB) continues to develop its broader ecosystem with Shibarium, the project’s Layer 2 network built to improve speed and lower gas fees. While the community remains strong, the price hasn’t followed suit lately. SHIB is currently trading around $0.00001298, and while that’s a decent jump from its earlier lows, it still falls short of triggering any major excitement across the market. The project includes additional tokens like BONE and LEASH, and also has ongoing initiatives in DeFi and NFTs. However, even with all this development, many investors feel the hype that once surrounded SHIB has shifted elsewhere, particularly toward newer, more dynamic meme coins offering better entry points and incentives. PEPE: Can it rebound or is the momentum gone? PEPE saw a parabolic rise during the last meme coin surge, catching fire on social media and delivering massive short-term gains for early adopters. However, like most meme tokens driven largely by hype, it has since cooled off. PEPE is currently trading around $0.00001076, down significantly from its peak. While the token still enjoys a loyal community, analysts believe its best days may be behind it unless…
Share
BitcoinEthereumNews2025/09/18 02:50